ELELVEarnings Analysis财报电话会Source pending来源待核by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：
ELV earnings call: Operating cash flow totaled $1.3 billion in the quarter, and we are raising our full-year operating cash flow guidance to at least $6.5 billion.Elevance Health, Inc. (ELV) 电话会：本季度运营现金流总计13亿美元，我们将全年运营现金流指引上调至至少65亿美元。
Management remarks
Call period: 2026 Q3 · 2026-10-21
Guidance: Mark Kaye: Operating cash flow totaled $1.3 billion in the quarter, and we are raising our full-year operating cash flow guidance to at least $6.5 billion.
Demand and orders: Gail Boudreaux: We continue to see strong demand for our Anthem Balance funded product and the differentiation created by our patient advocacy programs.
Margins: Mark Kaye: In Medicare Advantage, the product and geographic actions we took for 2026, along with the quality of our retained membership mix, support a full-year operating margin of at least 2%.
Analyst Q&A
Analyst A.J. Rice asked: And maybe any comment on the underlying cost trends assumed across the major business lines. Is that similar to 2026, or are you assuming any improvement when you talk about 12% earnings growth? Management Gail Boudreaux answered: I guess I would start with our confidence first is stronger because we're entering 2027 from a much higher earnings baseline and with stronger operating confidence and performance across the enterprise. As we shared, we remain confident in delivering at least the 12% adjusted EPS growth off the 2027 higher ending baseline of 2026 of $26.75. In terms of your question, we see a clear path through continued health benefit margin improvement, continued growth in our Carelon-based solutions, and a greater operating efficiency across our enterprise.
